Literature DB >> 17928414

Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors.

Jin Deok Joo1, Mihwa Kim, Patrick Horst, Jeehee Kim, Vivette D D'Agati, Charles W Emala, H Thomas Lee.   

Abstract

We showed previously that activation of A(1) adenosine receptors (AR) protects against renal ischemia-reperfusion (IR) injury in rats and mice. In the heart, transient A(1)AR activation produces biphasic protective effects: acute protection wanes after several hours but protective effects return 24-72 h later (second window of protection). In this study, we determined whether A(1)AR activation produces delayed renal protection and elucidated the mechanisms of acute and delayed renal protection. A(1)AR wild-type mice were subjected to 30-min renal ischemia and 24 h of reperfusion to produce acute renal failure. Pretreatment with a selective A(1)AR agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA; 0.1 mg/kg bolus ip) either 15 min or 24 h before renal ischemia protected against renal IR injury and reduced renal corticomedullary necrosis, apoptosis, and inflammation. Transient A(1)AR activation led to phosphorylation of extracellular signal-regulated protein kinase mitogen-activated protein kinase (ERK MAPK), Akt, and heat shock protein 27 (HSP27). Moreover, induction of HSP27 and Akt occurred with CCPA treatment. Inhibition of PKC with chelerythrine prevented acute but not delayed renal protection with A(1)AR activation. Moreover, deletion of PI3Kgamma or inhibition of Akt, but not inhibition of ERK, prevented delayed and acute renal protection with A(1)AR activation. Inhibition of G(i/o) with pertussis toxin obliterated both acute and delayed A(1)AR-mediated renal protection. In contrast to renal protection with delayed ischemic preconditioning, nitric oxide synthase activity was not induced with delayed A(1)AR-mediated renal protection. Therefore, transient activation of renal A(1)AR led to acute as well as delayed protective effects against renal IR injury via distinct signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928414     DOI: 10.1152/ajprenal.00336.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  33 in total

1.  Cardiomyocyte overexpression of the α1A-adrenergic receptor in the rat phenocopies second but not first window preconditioning.

Authors:  Xin Zhao; Jiyeon Park; David Ho; Shumin Gao; Lin Yan; Hui Ge; Siiri Iismaa; Lin Lin; Bin Tian; Dorothy E Vatner; Robert M Graham; Stephen F Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

Review 2.  Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Authors:  Hong Liu; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2015-08-27

Review 3.  Adenosine receptors and the kidney.

Authors:  Volker Vallon; Hartmut Osswald
Journal:  Handb Exp Pharmacol       Date:  2009

4.  Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis.

Authors:  György Haskó; Balázs Csóka; Balázs Koscsó; Rachna Chandra; Pál Pacher; Linda F Thompson; Edwin A Deitch; Zoltán Spolarics; László Virág; Pál Gergely; Rolando H Rolandelli; Zoltán H Németh
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

5.  Selective renal overexpression of human heat shock protein 27 reduces renal ischemia-reperfusion injury in mice.

Authors:  Minjae Kim; Sang Won Park; Mihwa Kim; Sean W C Chen; William T Gerthoffer; Vivette D D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-19

Review 6.  Purinergic regulation of the immune system.

Authors:  Caglar Cekic; Joel Linden
Journal:  Nat Rev Immunol       Date:  2016-03       Impact factor: 53.106

Review 7.  Advances in protein misfolding, amyloidosis and its correlation with human diseases.

Authors:  Debanjan Kundu; Kumari Prerna; Rahul Chaurasia; Manoj Kumar Bharty; Vikash Kumar Dubey
Journal:  3 Biotech       Date:  2020-04-04       Impact factor: 2.406

8.  Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.

Authors:  Katalin Módis; Domokos Gero; Nóra Nagy; Petra Szoleczky; Zoltán Dóri Tóth; Csaba Szabó
Journal:  Br J Pharmacol       Date:  2009-11       Impact factor: 8.739

9.  In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.

Authors:  Alexander Choukèr; Akio Ohta; André Martignoni; Dmitriy Lukashev; Lefteris C Zacharia; Edwin K Jackson; Jürgen Schnermann; Jerrold M Ward; Ines Kaufmann; Brenda Klaunberg; Michail V Sitkovsky; Manfred Thiel
Journal:  Transplantation       Date:  2012-11-15       Impact factor: 4.939

Review 10.  Renal hypoxia and dysoxia after reperfusion of the ischemic kidney.

Authors:  Matthieu Legrand; Egbert G Mik; Tanja Johannes; Didier Payen; Can Ince
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.